Mr. Speaker, we regularly disclose the number of vaccines we expect to receive. We are experiencing temporary delays with the two approved vaccines, but we will receive six million doses by the end of the first quarter.
COVAX was specifically designed so that Canada and other developed countries would receive vaccines during the first phase of the program, and then developing countries would receive vaccines in the second phase. Canada can be proud of its participation in COVAX.